Acrivon Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 8.34 M | $15.10 M | 0.00% | 21.69% |
| SANDS CAPITAL VENTURES, LLC | 11/13/2025 | 2.12 M | $3.84 M | 0.00% | 5.52% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.54 M | $2.79 M | -18.69% | 4.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 888.13 K | $1.61 M | 0.00% | 2.31% |
| UBS GROUP AG | 11/13/2025 | 683.22 K | $1.24 M | 150,057.80% | 1.78% |
| VANGUARD GROUP INC | 11/07/2025 | 626.15 K | $1.13 M | 5.55% | 1.63% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 623.40 K | $1.13 M | 22.40% | 1.62% |
| ACORN CAPITAL ADVISORS, LLC | 11/17/2025 | 405.24 K | $733.48 K | 0.00% | 1.05% |
| BLACKROCK, INC. | 11/12/2025 | 330.96 K | $599.03 K | -18.81% | 0.86% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 319.21 K | $577.76 K | 76.19% | 0.83% |
| JANE STREET GROUP, LLC | 11/14/2025 | 289.25 K | $523.54 K | -7.24% | 0.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 192.03 K | $347.72 K | 16.84% | 0.50% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 185.23 K | $335.27 K | -37.47% | 0.48% |
| MARSHALL WACE, LLP | 11/13/2025 | 149.72 K | $270.98 K | -17.37% | 0.39% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 136.50 K | $247.07 K | 318.71% | 0.35% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 104.32 K | $188.83 K | -31.64% | 0.27% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 92.00 K | $165.00 K | 100.00% | 0.24% |
| STATE STREET CORP | 11/14/2025 | 67.15 K | $121.53 K | 0.00% | 0.17% |
| MORGAN STANLEY | 11/14/2025 | 57.16 K | $103.46 K | -9.29% | 0.15% |
| ALGERT GLOBAL LLC | 11/14/2025 | 44.65 K | $81.00 K | 100.00% | 0.12% |
| NORTHERN TRUST CORP | 11/14/2025 | 42.17 K | $76.32 K | -9.86% | 0.11% |
| XTX TOPCO LTD | 11/14/2025 | 35.96 K | $65.08 K | -66.12% | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 22.90 K | $41.45 K | 0.00% | 0.06% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 22.81 K | $41.28 K | 0.00% | 0.06% |
| BARCLAYS PLC | 11/12/2025 | 19.97 K | $36.14 K | -4.59% | 0.05% |
| COLONY GROUP, LLC | 11/14/2025 | 19.85 K | $987.93 K | 100.00% | 0.05% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 19.74 K | $35.73 K | -85.90% | 0.05% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 19.58 K | $35.46 K | -11.82% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 18.90 K | $34.22 K | -8.31% | 0.05% |
| CITIGROUP INC | 11/10/2025 | 16.31 K | $29.51 K | -49.65% | 0.04% |
| AAF WEALTH MANAGEMENT, LLC | 11/12/2025 | 10.68 K | $19.33 K | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 8.74 K | $15.81 K | -1.22% | 0.02% |
| FMR LLC | 11/13/2025 | 8.62 K | $15.61 K | -12.47% | 0.02% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 11/10/2025 | 5.51 K | $9.98 K | -12.45% | 0.01% |
| FEDERATED HERMES, INC. | 11/03/2025 | 2.43 K | $4.39 K | 4.66% | 0.01% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.74 K | $3.15 K | 22.78% | 0.00% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 11/03/2025 | 1.22 K | $2.20 K | 0.41% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 1.19 K | $2.15 K | 19.86% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2025 | 948 | $2.00 K | 100.00% | 0.00% |
| GF FUND MANAGEMENT CO. LTD. | 11/07/2025 | 650 | $1.18 K | -15.80% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 10/23/2025 | 584 | $1.06 K | 0.00% | 0.00% |
| REDWOOD PARK ADVISORS LLC | 11/14/2025 | 500 | $905 | 0.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 481 | $871 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/14/2025 | 400 | $724 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 373 | $675 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 74 | $134 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Acrivon Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 61 institutional investors and hedge funds held shares of Acrivon Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 8.34 M
Sands Capital Ventures, LLC: 2.12 M
CITADEL ADVISORS LLC: 1.54 M
WELLINGTON MANAGEMENT GROUP LLP: 888,130
UBS Group AG: 683,218
VANGUARD GROUP INC: 626,148
45.45% of Acrivon Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 18.55 M shares in the last 24 months. This purchase volume represents approximately $35.42 M in transactions.